YU-Jung Jenny Wei

Has grant

Associate Professor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Yu-Jung Jenny Wei is an Associate Professor at The Ohio State University, USA. Her research primarily focuses on opioid use, outcomes in older adults, and the effects of CYP2D6 metabolism on treatment responses. Recent articles include studies on unrelieved pain and the risks of opioid use disorder, as well as the cognitive effects of prescription opioids in older adults with chronic pain.

Recent Grants

Grant: Close

Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults

Open Date: 2019-09-01

Close Date: 2022-08-31

Grant: Close

Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia

Open Date: 2017-08-01

Close Date: 2022-05-31

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Roger Fillingim

University of Florida

UNITED STATES

View details

Yan Gong

UNITED STATES

View details

Julie A. Johnson

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

YU-Jung Jenny Wei

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioids

CYP2D6 Phenotypes and Emergency Department Visits Among Patients Receiving Opioid Treatment.

Association of initiating CYP2D6-metabolized opioids with risks of adverse outcomes in older adults receiving antidepressants: A retrospective cohort study

Outcomes of Discontinuing Long-Term Opioid Therapy among Older Cancer Survivors in Long-Term Care Settings

Prescription opioid use and cognitive function in older adults with chronic pain: A population‐based longitudinal cohort study

Use of CYP2D6 Inhibitors with CYP2D6 Opioids: Association with Emergency Department Visits for Pain

Clinical and Adverse Outcomes Associated With Concomitant Use of CYP2D6-Metabolized Opioids With Antidepressants in Older Nursing Home Residents

Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study

Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer’s disease and related dementia

Pain intensity, physical function, and depressive symptoms associated with discontinuing long‐term opioid therapy in older adults with Alzheimer's disease and related dementias

Perioperative Use of Gabapentinoids and Risk for Postoperative Long-Term Opioid Use in Older Adults Undergoing Total Knee or Hip Arthroplasty.

Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data.

Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.

Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.

Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes.

Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy.

Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study.

Collaborators (3)

Roger Fillingim

Yan Gong

Julie A. Johnson

Make your next move.